biote Croissance future
Future contrôle des critères 4/6
biote is forecast to grow earnings and revenue by 73.2% and 16% per annum respectively while EPS is expected to grow by 68.4% per annum.
Informations clés
73.2%
Taux de croissance des bénéfices
68.4%
Taux de croissance du BPA
| Pharmaceuticals croissance des bénéfices | 23.7% |
| Taux de croissance des recettes | 16.0% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 28 Oct 2024 |
Mises à jour récentes de la croissance future
Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | 276 | 22 | 37 | 38 | 2 |
| 12/31/2025 | 232 | 23 | 40 | 46 | 5 |
| 12/31/2024 | 202 | 1 | 37 | 40 | 5 |
| 6/30/2024 | 187 | 7 | 19 | 24 | N/A |
| 3/31/2024 | 187 | 8 | 18 | 21 | N/A |
| 12/31/2023 | 185 | 3 | 24 | 27 | N/A |
| 9/30/2023 | 184 | -3 | 24 | 26 | N/A |
| 6/30/2023 | 181 | -10 | 30 | 32 | N/A |
| 3/31/2023 | 173 | -8 | -5 | -3 | N/A |
| 12/31/2022 | 165 | -1 | -11 | -9 | N/A |
| 9/30/2022 | 158 | 3 | -8 | -5 | N/A |
| 6/30/2022 | 152 | 11 | -9 | -5 | N/A |
| 3/31/2022 | 145 | 24 | 29 | 33 | N/A |
| 12/31/2021 | 139 | 33 | 30 | 34 | N/A |
| 9/30/2021 | 133 | 37 | 28 | 31 | N/A |
| 12/31/2020 | 117 | 29 | 25 | 26 | N/A |
| 12/31/2019 | 110 | 21 | 24 | 25 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: BTMD's forecast earnings growth (73.2% per year) is above the savings rate (2.5%).
Bénéfices vs marché: BTMD's earnings (73.2% per year) are forecast to grow faster than the US market (15.4% per year).
Croissance élevée des bénéfices: BTMD's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: BTMD's revenue (16% per year) is forecast to grow faster than the US market (8.9% per year).
Croissance élevée des revenus: BTMD's revenue (16% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if BTMD's Return on Equity is forecast to be high in 3 years time